Farah Abid, Muhammad Saleem, Saleha Yasir, Shumila Arshad, Sundus Qureshi, Mayyda Asif Bajwa, Sana Ashiq, Samreen Tanveer, Mehiwh Qayyum, Kanwal Ashiq


Cancer has been a fatal disease since many decades. Over the time, it is presented in multiple ways and is a matter of consideration as accounts for the high rate of mortality. The aim of the current review was to focus on the genetics, epigenetics factors and role of medicinal plants for the cure of this inimical disease. Related articles available in English language (2002-2018) were reviewed with help of different database, including PubMed, Springer Link, Medline, Google Scholar and ScienceDirect. In order to ensure credibility and accuracy of data only those articles were considered which are published in indexed journals i.e. Web of Science and Scopus. This project was conducted at the Department of Pharmacy, Government College University, Faisalabad, Pakistan from 02-01-2019 to 28-02-2019. The genetic machinery is vibrantly involved in the interpretation of the signals and is observed to be affected by various dietary factors. A sequence of modified activities is observed with use of these dietary elements. However, the modification is reviewed through the histone acetyltransferase (HAT), histone deacetylase (HDAC) and DNA methyl transferase (DNMTs), effecting the expression of gene. These modified genes, in turn then express the signals in multiple reformed ways. Different dietary elements that are used such as polyphenol, alkaloid and flavonoids are effective against cancer. The progression of disease involves genetics and epigenetics due to amplification, translocation and mutation during gene expression. Though, many studies have been conducted elaborating the role of plants and their ingredients which play a part in inhibition of cancerous cells by blockade of cell cycle and apoptosis; more in-depth investigations are still required to identify the new drug target and novel therapeutic modalities.


Cancer; Epigenetics; Histone Acetyltransferase; Histone Deacetylase; Medicinal Plants.

Full Text:



Pitot HC. Fundamentals of Oncology, Revised and expanded. 4th ed. Florida: CRC Press; 2002.

Boveri T. The Origin of Malignant Tumors. Williams and Wilkins: Baltimore, MD;1929.

Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006 Jan;7(1):21-33.

Szulwach KE, Jin P. Integrating DNA methylation dynamics into a framework for understanding epigenetic codes. Bioessays 2014 Jan;36(1):107-17.

Davis CD, Ross SA. Dietary components impact histone modifications and cancer risk. Nutr Rev 2007 Feb 1;65(2):88-94.

Ducasse M, Brown MA. Epigenetic aberrations and cancer. Mol Cancer 2006 Dec 1;5(1):60.

Nian H, Bisson WH, Dashwood WM, Pinto JT, Dashwood RH. α-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells. Carcinogenesis 2009 Aug 1;30(8):1416-23.

Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002 Jan 1;16(1):6-21.

Volpe T, Schramke V, Hamilton GL, White SA, Teng G, Martienssen RA, et al. RNA interference is required for normal centromere function infission yeast. Chromosome Res 2003 Feb 1;11(2):137-46.

Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009 Feb 1;30(2):85-94.

Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008 Dec 1;76(11):1590-611.

Marcu L, Olver I. Tirapazamine: from bench to clinical trials. Curr Clin Pharmacol 2006 Jan 1;1(1):71-9.

Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008 Mar 3;118(3):868-78.

Xie P, Zhang W, Yuan S, Chen Z, Yang Q, Yuan D. Suppression of experimental choroidal neovascularization by curcumin in mice. PloS one 2012; 7(12):e53329. doi: 10.1371/journal.pone.0053329.

Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-κB. Nutr 2009 Sep 1;25(9):964-72.

Gracia A, Elcoroaristizabal X, Fernández-Quintela A, Miranda J, Bediaga NG, de Pancorbo MM, et al. Fatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds. Genes Nutr 2014 Jul 1;9(4):411.

Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics 2011 Dec;3(1):4.

Kai L, Samuel SK, Levenson AS. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer 2010 Apr 1;126(7):1538-48.

Binda O, Nassif C, Branton PE. SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins. Oncogene 2008 May;27(24):3384-92.

Ndiaye M, Kumar R, Ahmad N. Resveratrol in cancer management: where are we and where we go from here? Ann N Y Acad Sci 2011 Jan;1215(1):144-9.

Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr 2010 Sep 1;140(9):1607-14.

Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 Sep;425(6954):191-6.

Roy AM, Baliga MS, Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 2005 Jan 1;4(1):81-90.

Li Y, Li X, Guo B. Chemopreventive agent 3, 3′-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases. Cancer Res 2010 Jan 15;70(2):646-54.

Gu B, Ding Q, Xia G, Fang Z. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncol Rep 2009 Mar 1;21(3):635-40.

Lee YH, Kwak J, Choi HK, Choi KC, Kim S, Lee J, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. Int J Mol Med 2012 Jul 1;30(1):69-74.

Chen H, Li Y, Tollefsbol TO. Strategies targeting telomerase inhibition. Mol Biotechnol 2009 Feb 1;41(2):194-9.

Choi KC, Jung MG, Lee YH, Yoon JC, Kwon SH, Kang HB, et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009 Jan 15;69(2):583-92.

Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 2010 Dec;1(3):101.

Li Y, Yuan YY, Meeran SM, Tollefsbol TO. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. Mol cancer 2010 Dec 1;9(1):274.

King-Batoon A, Leszczynska JM, Klein CB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 2008 Jan;49(1):36-45.

Chen Y, Huang C, Zhou T, Chen G. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin Pharmacol Toxicol 2008 Dec;103(6):553-9.

Chang KL, Cheng HL, Huang LW, Hsieh BS, Hu YC, Chih TT, et al. Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line. Cancer Lett 2009 Apr 8;276(1):14-20.

Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008 Oct 8;269(2):226-42.

Lee JY, Kim HS, Song YS. Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med 2012 Apr 1;2(2):96-104.

Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer 2004 Jul 1;49(2):125-30.

Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007 Mar 1;6(3):1013-21.

McCullough ML, Robertson AS, Chao A, Jacobs EJ, Stampfer MJ, Jacobs DR, et al. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Cause Control 2003 Dec 1;14(10):959-70.

Sivils JC, Ancrum TM, Bain LJ. LOSS of Mrp1 alters detoxification enzyme expression in a tissue-and hormonal-status-specific manner. J Appl Toxicol 2013 Aug;33(8):766-73.

Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, et al. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 2004 Jun 11;279(24):25813-22.

Jeong JK, Moon MH, Seo JS, Seol JW, Lee YJ, Park SY. Sulforaphane blocks hypoxia-mediated resistance to TRAIL-induced tumor cell death. Mol Med Rep 2011 Mar 1;4(2):325-30.

Chalabi N, Delort L, Le Corre L, Satih S, Bignon YJ, Bernard-Gallon D. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 2006 Aug 3;7(5):1-10.

Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers 2001 Jul 1;10(7):749-56.

Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 2002 Nov;227(10):881-5.

Arshad S, ur Rehman M, Abid F, Yasir S, Qayyum M, Ashiq K, et al. Current situation of breast cancer in Pakistan with the available interventions. Int J Biosci 2019;11(6):232-40.

Tan S, Wang C, Lu C, Zhao B, Cui Y, Shi X, et al. Quercetin is able to demethylate the p16INK4a gene promoter. Chemotherapy 2009;55(1):6-10.

Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep 2011 Feb 1;25(2):583-91.

Xiao X, Shi D, Liu L, Wang J, Xie X, Kang T, et al. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PloS One 2011;6(8):e22934. doi: 10.1371/journal.pone.0022934.

Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, et al. Polyisoprenylatedbenzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004 Aug 6;279(32):33716-26.

Jeong HJ, Jeong JB, Kim DS, de Lumen BO. Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem 2007 Feb 7;55(3):632-7.

Pajak B, Gajkowska B, Orzechowski A. Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol 2008;46(2):129-35.

Qayyum M, Ashiq K, Tanveer S, Bajwa MA, Shah-Rukh A, Jahangir N, et al. Review on phytochemical evaluation and extraction of Nigella sativa (Kalongi) with pharmacological and traditional applications. Int J Biosci 2020 Mar 18;16(3): 231-41.

Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 2003 May 23;278(21):19134-40.

Nian H, Delage B, Ho E, Dashwood RH. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 2009 Apr;50(3):213-21.

Lea MA, Rasheed M, Randolph VM, Khan F, Shareef A, DesBordes C. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutr Cancer 2002 May 1;43(1):90-102.

Nian H, Delage B, Pinto JT, Dashwood RH. Allylmercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis 2008 Sep 1;29(9):1816-24.

Xiao D, Zeng Y, Singh SV. Diallyltrisulfide-induced apoptosis in human cancer cells is linked to checkpoint kinase 1-mediated mitotic arrest. Mol Carcinog 2009 Nov;48(11):1018-29.

Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN. Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta 2009 Nov 1;1790(11):1541-5.

Lee JI, Nian H, Cooper AJ, Sinha R, Dai J, Bisson WH, et al. α-Keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells. Cancer Prev Res 2009 Jul 1;2(7):683-93.

Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007 Oct 28;13(40):5299.

Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009 Apr 28;15(16):1943.

Mateen S, Raina K, Jain AK, Agarwal C, Chan D, Agarwal R. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics 2012 Oct 13;7(10):1161-72.

Petersen M, Simmonds MS. Rosmarinic acid. Phytochemistry 2003 Jan 1;62(2):121-5.

Paluszczak J, Krajka-Kuźniak V, Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 2010 Feb 1;192(2):119-25.

Xu Y, Jiang Z, Ji G, Liu J. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. Planta Med 2010 Jul;76(10):956-62.

Tian L, Yin D, Ren YE, Gong C, Chen A, Guo FJ. Plumbagin induces apoptosis via the p53 pathway and generation of reactive oxygen species in human osteosarcoma cells. Mol Med Rep 2012 Jan 1;5(1):126-32.

Gomathinayagam R, Sowmyalakshmi S, Mardhatillah F, Kumar RA, Akbarsha MA, Damodaran C. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res 2008 Mar 1; 28(2A):785-92.

Lee JH, Yeon JH, Kim H, Roh W, Chae J, Park HO, et al. The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation. PloS One 2012; 7(9):e45023. doi: 10.1371/journal.pone.0045023.

Li J, Shen L, Lu FR, Qin Y, Chen R, Li J, et al. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacol Sin 2012 Feb;33(2):242-9.

Yang R, Hanwell H, Zhang J, Tsao R, Meckling KA. Antiproliferative activity of pomiferin in normal (MCF-10A) and transformed (MCF-7) breast epithelial cells. J Agric Food Chem 2011 Dec 28;59(24):13328-36.

Gruber JV, Holtz R, Sikkink SK, Tobin DJ. In vitro and ex vivo examination of topical Pomiferin treatments. Fitoterapia 2014 Apr 1;94:164-71.

Sun M, Lou W, Chun JY, Cho DS, Nadiminty N, Evans CP, et al. Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer 2010 Mar;1(3):283-92.

Tsukamoto H, Kondo S, Mukudai Y, Nagumo T, Yasuda A, Kurihara Y, et al. Evaluation of anticancer activities of benzo [c] phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. Anticancer Res 2011 Sep 1;31(9):2841-6.



  • There are currently no refbacks.

Copyright (c) 2020 Farah Abid, Muhammad Saleem, Saleha Yasir, Shumila Arshad, Sundus Qureshi, Mayyda Asif Bajwa, Sana Ashiq, Samreen Tanveer, Mehiwh Qayyum, Kanwal Ashiq

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.